<PAGE>2                      
                           UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION
                    Washington, D.C. 20549

                          FORM 10-QSB

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES AND EXCHANGE ACT OF 1934
For the Quarter ended July 31, 1998

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE 
      EXCHANGE ACT
For the transition period 			 to 			

Commission file number     -    0-25614

                GLOBUS CELLULAR, LTD.
                (formerly Globus Cellular & User Protection, Ltd.)
          (Exact name of Small Business Issuer in its charter)

	NEVADA	                                       88-0228274
(State or other jurisdiction of	                  (I.R.S. Employer
incorporation or organization)  	                 Identification No.)


	1980 Windsor Road
	Kelowna, British Columbia, Canada	                V1Y 4R5	
	(Address of principal executive offices)	      (Zip Code)

Registrant's Telephone number, including area code:    (604) 860-3130

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities and Exchange 
Act of 1934 during the preceding twelve months (or such shorter period that 
the Registrant was required to file such reports), and (2) has been subject 
to 
file such filing requirements for the past thirty days.

Yes    x      No	
      -------        --------

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the close of the period covered by this report:

                7,289,866 Shares of Common Stock ($.001 par value)
                           (Title of Class)

Transitional Small Business Disclosure Format (check one):      
Yes             No     x
      ---------       --------	  










<PAGE> 3
                        GLOBUS CELLULAR, LTD.



PART I:	Financial Information

	ITEM 1 - Financial statements

	ITEM 2 - Management's' discussion and analysis of 
	financial condition and results of operations

PART II:	Other Information

	ITEM 6 - Exhibits and Reports on Form 8-K










<PAGE> 4
                                            PART I

Item 1. Financial Statements:

Globus Cellular Ltd.
Balance Sheet
July 31, 1998
<TABLE>
<CAPTION>
                       ASSETS
<S>                                                      <C> 
Current assets:
  Cash                                               $    112,366
  Accounts receivable, trade                                3,652
  Accounts receivable, other                                6,811
  Inventories                                              60,355
  Prepaid expenses                                         31,426
  Prepaid expenses - related party                           -
                                                      -----------
      Total current assets                                214,611

Property and equipment, at cost, less
  accumulated depreciation of $50,093                      52,121

Other assets                                               20,104
                                                      -----------
                                                      $   286,836
                                                      ===========


        LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                                    $    10,267
  Loans from stockholders                                 155,103
                                                      -----------
      Total current liabilities                           165,370


Stockholders' equity:
 Preferred stock, $.001 par value,
  20,000,000 shares authorized,                                 -
 Common stock, $.001 par value,
  100,000,000 shares authorized,
  7,289,866 shares issued and
  outstanding                                               7,290
 Additional paid-in capital                             3,419,382
 Stock subscriptions                                       42,534
 Foreign exchange adjustment                              (30,099)
 (Deficit)                                             (3,317,641)
                                                      -----------
                                                          121,466
                                                      -----------
                                                      $   286,836
                                                      ===========

</TABLE>

See accompanying notes to financial statements.



<PAGE>5

Globus Cellular Ltd.
Statements of Operations
Three Months and Nine Months Ended July 31, 1998 and 1997
<TABLE>
<CAPTION>
                                  Three Months         Three Months        Nine Months          Nine Months
                                     Ended               Ended               Ended               Ended     
                                    July 31,            July 31,            July 31,            July 31,
                                      1998                1997                1998                1997
                                    --------            --------            --------            --------
<S>                                   <C>                  <C>                  <C>                <C>
Revenue:
 Sales                            $    15,874          $   14,323         $    50,302  $           74,177 
 Other income                           1,309               9,360              12,148              28,603 
                                  -----------         -----------         -----------         ----------- 
                                       17,182              23,683              62,449            102,780  

Other costs and expenses:
 Cost of sales                          3,047               5,392             24,412              46,556  
 General and administrative           126,950             218,476            537,343             663,361  
 Research and development              19,895               8,984             46,938              28,170  
                                  -----------         -----------         -----------         ----------- 
                                      149,892             232,852            608,693             738,087 
                                  -----------         -----------         -----------         ----------- 
Income (loss) from operations        (132,710)           (209,169)          (546,244)           (635,307)

Other income and (expense):
 Interest expense                        (327)               (190)            (8,677)             (2,439)
                                  -----------         -----------         -----------         -----------
                                         (327)               (190)            (8,677)             (2,439)
                                  -----------         -----------         -----------         -----------
Income (loss) before income taxes    (133,037)           (209,359)          (554,921)           (637,746)
Provision for income taxes               
-
                                  -----------         -----------         -----------         -----------
  Net income (loss)               $  (133,037)        $  (209,359)        $ (554,921)         $ (637,746)
                                  ===========         ===========         ===========         =========== 

Basic (loss) per share:
 Net income (loss)                $    (0.02)              (0.05)         $    (0.08)              (0.16)
                                  ===========         ===========         ===========         ===========

 Weighted average shares
  outstanding                       7,289,866           4,223,830           7,212,828           4,074,391
                                  ===========         ===========         ===========         ===========

</TABLE>



See accompanying notes to financial statements.




<PAGE>6

Globus Cellular Ltd.
Statements of Cash Flows
Nine Months Ended July 31, 1998

<TABLE>
<CAPTION>
                                              Nine Months         Nine Months
                                                 Ended               Ended
                                                July 31,            July 31,
                                                  1998                1997
                                                --------            --------
<S>                                               <C>                <C>
  Net cash provided by (used in)
   operating activities                       $ (245,017)        $  (98,267)
                                              ----------         ----------

Cash flows from investing activities:
  Purchase of equipment                          (38,462)           (18,465)
                                               ----------         ---------
  Net cash provided by (used in)
   investing activities                          (38,462)           (18,465)

Cash flows from financing activities:
  Common stock sold for cash                      59,199             48,073
  Increase on common stock subscribed             42,534                  -
  Increase in officer loans                                          47,309
  Repayment of officer loans                     (55,021)                 -
                                               ---------          ---------
  Net cash provided by (used in)
   financing activities                           46,712             95,382
                                               ---------          ---------
Increase (decrease) in cash                     (236,767)           (21,350)
Cash and cash equivalents,
 beginning of period                             349,133             40,009
                                                --------          ---------
Cash and cash equivalents,
 end of period                                 $ 112,366          $  18,659
                                               =========          =========

</TABLE>



See accompanying notes to financial statements.




<PAGE>7

Globus Cellular & User Protection, Ltd.
Notes to Financial Statements


Basis of presentation

The accompanying condensed unaudited financial statements have 
been prepared in accordance with generally accepted accounting 
principles for interim financial information and with the 
instructions to form 10-QSB. Accordingly, they do not include all 
of the information and footnotes required by generally accepted 
accounting principles for complete financial statements. In the 
opinion of management, all adjustments (consisting of normal 
recurring adjustments) considered necessary for a fair 
presentation have been included.

The results of operations for the periods presented are not 
necessarily indicative of the results to be expected for the full 
year. The accompanying financial statements should be read in 
conjunction with the Company's form 10-KSB filed for the year 
ended October 31, 1997.

Stockholders' equity

Basic (loss) per share was computed using the weighted average 
number of common shares outstanding.

During the period ended April 30, 1998 the Company issued 137,053 
shares of its common stock pursuant to a registration statement 
on Form S-8.  The shares issued were valued at $95,193 based on 
quoted market prices at the date the shares were authorized for 
issuance.  Additionally during the period, the Company issued 
69,500 shares of its restricted common stock for services 
provided to the Company valued at $32,315, completed the private 
sale of 72,500 shares of restricted common stock for net cash 
proceeds of $50,949, and issued 50,000 shares of restricted 
common stock pursuant to the exercise of stock options for which 
the Company received $8,250 in cash  Additionally, during the 
quarter ended July 31, 1998, the Company received $42,534 in cash 
for subscriptions to 140,039 shares of common stock which will be 
issued in the fourth quarter.

During the nine months ended July 31, 1998, the Company continued 
to amortize unpaid stock subscriptions for shares issued in prior 
periods for future services.  An aggregate of $72,690 of 
consulting services and directors compensation is included in 
general and administrative expense for period ended July 31, 
1998.




<PAGE> 8

                    GLOBUS CELLULAR, LTD.

PART I (cont.)

Item 2. Management's Discussion and Analysis of Financial 
Condition and Results of Operations:

Capital Resources and Liquidity.

During the period ended July 31, 1998, the Company issued 137,053 shares of 
its common stock pursuant to a registration statement of Form S-8.    The 
shares issued were valued at $95,193 based on quoted market prices at the 
date the shares were authorized for issuance.   Additionally during the 
period, the Company issued 69,500 shares of its restricted common stock for 
services provided to the Company valued at $32,315, completed the private 
sale of 72,500 shares of restricted common stock for net cash proceeds of 
$50,949, and issued 50,000 shares of restricted common stock pursuant to the 
exercise of stock options for which the Company received $8,250 in cash. 
Additionally, during the quarter ended July 31, 1998, the Company received 
$42,534 in cash for subscriptions to 140,039 shares of common stock which 
will be issued in the fourth quarter.  

For the nine months ended July 31, 1998, the Company repaid $55,021 in 
officer loans.  Officer loans increased by $47,309 for the nine months ended 
July 31, 1998.   As a result, net cash provided by financing activities for 
the nine months ended July 31, 1998 was $95,382.

During the period ended July 31, 1998, the Company continued to amortize 
unpaid stock subscriptions for shares issued in prior periods for future 
services.   An aggregate of $72,690 of consulting services and directors 
compensation is included in general and administrative expense for the 
period.

During the nine months ended July 31, 1997, two of the Company's officers 
agreed to forego cash payments for salary and technology lease payments 
accrued during the quarter in exchange for common stock of the Company.  The 
restricted shares to be issued to the officers in lieu of cash payments of 
$101,250 were valued at $.22 per share, an amount equal to one-half of the 
bid price for the Company's common stock on the date the transaction was 
approved by the Company's board of directors.  Additionally one of the 
officers received 110,720 shares of restricted common stock for services 
rendered during the second quarter of the current fiscal year and for 
payment of other amounts due him.  The aggregate value of the stock issued 
was $23,930.

During the nine months ended July 31, 1997, the Company sold its interest the 
building used for its office and warehouse activities to its president.  The 
Company recorded a gain from the transaction of $5,604.  Corresponding 
reductions of mortgage indebtedness of $60,960 and amounts due its president 
of $33,205 were recorded in connection with the transaction.  The Company 
plans to lease the facility from its president at market rates.

During the nine months ended July 31, 1997, the Company issued 32,049 shares 
of its restricted common stock pursuant to the exercise of warrants for cash 
aggregating $48,073.   Additionally, the Company received additional
shareholder loans ($47,309) resulting in net cash provided by financing 
activities of $95,382 for the nine months ended July 31, 1997.

The Company acquired plant and equipment valued at $38,462 for the nine 
months ended July 31, 1998.   This resulted in net cash used in investing 
activities of $38,462.   The Company does not anticipate purchasing any 
additional plant or significant equipment and does not expect any significant 
changes in the number of its employees, nor does Company expect to perform 
any material product research and development during the next twelve (12) 
months.

The Company acquired plant and equipment valued at $18,465 for the nine 
months ended July 31, 1997.   This resulted in net cash used in investing 
activities of $18,465.

Long-term liquidity will be dependent on anticipated future revenue.   
Additionally, the Company shall pursue a registration of its Common Shares 
and Class "A" Warrants and will, in part, rely on the subsequent exercise of 
said Warrants.   Any additional funds raised and any revenues received from 
sale of Company's products will enable Company to expand its plan of 
operations by increasing its production and expanding its product line.

The Company is not presently aware of any known trends, events or 
uncertainties that may have a material impact on net sales, revenues or 
income from its operations.  However, Company's product is new in the market 
and there are not assurances it can be marketed successfully and/or 
profitably.





<PAGE>9


Results of Operations.	

The Company experienced a net loss from operating activities of $637,746 for 
the nine months ended July 31, 1998.   Total Sales were $50,302 for the nine 
months ended July 31, 1998 and decreased from $74,177 for the nine months 
ended July 31, 1997.   Cost of Sales, however, were $24,412 and $46,566 for 
the same periods, respectively.   No CUP products were sold during the 
periods presented.    Substantial selling, general and administrative 
expenses of $537,343 were incurred for the nine months ended July 31, 1998 
due to the Company's increased operations compared to $663,671 for the same 
period in 1997.   Selling, general and administrative expenses consisted 
primarily of accounting of $16,733, consulting expense of $194,111, Freight 
of $4,170, legal fees of $26,892, office expense of $10,736, promotion 
expense of $28,161, rent expense of $8,096, technology lease expense of 
$90,000, telephone expense of $5,643, travel of $11,898, wages of $54,709, 
management contract payments of $67,500 and other expenses of $18,694.  The 
Company expended $46,938 and $28,170 on  research and development expenses 
for the nine months ended July 31, 1998 and 1997, respectively.

The Company experienced a net loss from operating activities of $98,267 for the 
nine months ended July 31, 1997.   Total Sales were $14,323 for the three 
months ended July 31, 1997 and $74,177 for the nine months ended July 31, 1997.
Cost of Sales, however, were $5,392 and $46,556 for the same periods 
respectively.  Substantial selling, general and administrative expenses of 
$218,477 were incurred for the three months ended July 31, 1997 and $663,362 for
the nine months ended July 31, 1997 due to the Company's increased operations.  
The Company expended $8,984 on  research and development expenses for the three 
months ended July 31, 1997 and $28,170 for the nine months ended July 31, 1997
due to the stage of development of the C.U.P. product and commencement of 
sale of said product.   








<PAGE>10

                 GLOBUS CELLULAR, LTD.

PART II


Item 6. Exhibits and Reports on Form 8-K  

	(a)	Exhibits (numbered in accordance with Item 601 of 
		Regulation S-K)

		None

	(b)	Reports on Form 8-K
		
		None










 


                       SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.




Date:	September 21, 1998          	/s/  Dr. Paul F. Bickert
                                             -------------------------------
		
					Dr. Paul F. Bickert, President